Status:
COMPLETED
γ-irradiated BCG to Train Innate Immunity
Lead Sponsor:
Radboud University Medical Center
Conditions:
Innate Immune Response
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Rationale: The live attenuated Bacillus Calmette-Guerin (BCG) vaccine protects against extrapulmonary infection with Mycobacterium tuberculosis and leprosy. It has been shown that vaccination with BCG...
Detailed Description
1. INTRODUCTION AND RATIONALE The live attenuated Bacillus Calmette-Guerin (BCG) vaccine protects against extrapulmonary infection with Mycobacterium tuberculosis and against leprosy \[1, 2\]. It ...
Eligibility Criteria
Inclusion
- The subjects must be healthy adults, aged 18 - 55 years old
Exclusion
- Subjects are excluded when they are from tuberculosis endemic countries, if they have been in contact with tuberculosis patients or if they have been earlier vaccinated with BCG.
- The subjects are excluded from the study if they suffer for any disease, including intercurrent infections.
- Subjects are not allowed to use any medication except oral anticonceptive agents.
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02259608
Start Date
November 1 2013
End Date
April 1 2014
Last Update
June 29 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.